Jinyu Bio-technology Co., Ltd. (SHA:600201)
China · Delayed Price · Currency is CNY 11.67
-0.44 (-3.63%)
May 29, 2026, 3:00 PM CST
Jinyu Bio-technology Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 104.27 | 100.11 | 108.99 | 283.63 | 210.66 | 382.29 |
Depreciation & Amortization | 253.38 | 253.38 | 216.87 | 189.26 | 200.16 | 191.59 |
Other Amortization | 7.12 | 7.12 | 1.35 | 0.25 | 0.3 | 0.31 |
Loss (Gain) From Sale of Assets | -8.38 | -8.38 | -2.58 | 0.04 | 0.04 | 2.31 |
Asset Writedown & Restructuring Costs | 2.91 | 2.91 | 14.33 | 23.42 | 66.56 | 41.75 |
Loss (Gain) From Sale of Investments | 4.01 | 4.01 | 9.49 | 7.78 | 9.81 | -3.19 |
Stock-Based Compensation | - | - | -4.52 | 57.22 | - | - |
Provision & Write-off of Bad Debts | 48.17 | 48.17 | 30.11 | 23.27 | 1.55 | 0.97 |
Other Operating Activities | -46.46 | -27.49 | -30.44 | -27.27 | -26.54 | 4.86 |
Change in Accounts Receivable | 30.48 | 30.48 | 14.99 | -67.03 | -70.17 | -125.1 |
Change in Inventory | 9.34 | 9.34 | 14.25 | 8.54 | -20.54 | 25.86 |
Change in Accounts Payable | -83.29 | -83.29 | -83.78 | -70.18 | -29.58 | 4.67 |
Change in Other Net Operating Assets | - | - | - | - | - | 11.08 |
Operating Cash Flow | 301.31 | 316.12 | 289.55 | 414.83 | 344.65 | 533.08 |
Operating Cash Flow Growth | 11.56% | 9.17% | -30.20% | 20.36% | -35.35% | -23.80% |
Capital Expenditures | -145.88 | -121.43 | -89.67 | -273.17 | -190.11 | -372.68 |
Sale of Property, Plant & Equipment | 9.31 | 9.32 | 0.84 | 0.01 | 0.26 | 0.54 |
Cash Acquisitions | 7.12 | 7.12 | - | - | - | - |
Divestitures | 0.18 | 0.18 | - | - | - | - |
Investment in Securities | 68.41 | -128.05 | -408.56 | -491.15 | 210.59 | -66.14 |
Other Investing Activities | -55.73 | 27 | 44.24 | 24.2 | 35.88 | 10.16 |
Investing Cash Flow | -116.59 | -205.85 | -453.15 | -740.11 | 176.62 | -548.12 |
Short-Term Debt Issued | - | - | 15 | - | 60 | - |
Total Debt Issued | - | - | 15 | - | 60 | - |
Short-Term Debt Repaid | - | -15 | - | -10 | - | - |
Long-Term Debt Repaid | - | -1.74 | -1.88 | -0.78 | -0.83 | -0.5 |
Total Debt Repaid | -16.74 | -16.74 | -1.88 | -10.78 | -0.83 | -0.5 |
Net Debt Issued (Repaid) | -16.74 | -16.74 | 13.12 | -10.78 | 59.18 | -0.5 |
Issuance of Common Stock | - | - | 6.15 | 185.03 | - | 13.12 |
Repurchase of Common Stock | -162.23 | -162.23 | -6.14 | - | -366.14 | -1.66 |
Common Dividends Paid | -33.23 | -33.32 | -89.37 | -66.81 | -124.38 | -134.23 |
Other Financing Activities | -72.45 | -95.16 | 0.99 | 3.94 | -5.96 | - |
Financing Cash Flow | -284.65 | -307.44 | -75.24 | 111.38 | -437.29 | -123.28 |
Foreign Exchange Rate Adjustments | - | - | 0 | -0 | 0.1 | -0.08 |
Net Cash Flow | -99.94 | -197.18 | -238.84 | -213.9 | 84.07 | -138.4 |
Free Cash Flow | 155.42 | 194.69 | 199.89 | 141.67 | 154.54 | 160.4 |
Free Cash Flow Growth | -23.30% | -2.60% | 41.09% | -8.33% | -3.65% | -65.97% |
Free Cash Flow Margin | 11.17% | 13.94% | 15.92% | 8.86% | 10.11% | 9.03% |
Free Cash Flow Per Share | 0.14 | 0.17 | 0.18 | 0.13 | 0.14 | 0.14 |
Cash Income Tax Paid | 109.33 | 96.04 | 97.75 | 141.79 | 106.65 | 115.63 |
Levered Free Cash Flow | 99.35 | 208 | 264.88 | 281.55 | 138.84 | -136.56 |
Unlevered Free Cash Flow | 99.4 | 208.29 | 268.32 | 281.59 | 141.85 | -136.54 |
Change in Working Capital | -63.72 | -63.72 | -54.04 | -142.76 | -117.9 | -87.8 |